Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.
Authors: Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Čičátková P; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Kováčová L; Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic., Jarošová M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Karas M; Department of Hematology and Oncology, University Hospital Plzeň, Plzeň, Czech Republic., Jindra P; Department of Hematology and Oncology, University Hospital Plzeň, Plzeň, Czech Republic., Klamová H; Institute of Hematology and Blood Transfusion, Praha, Czech Republic., Poláková KM; Institute of Hematology and Blood Transfusion, Praha, Czech Republic., Černá O; Department of Hematology, University Hospital Královské Vinohrady, Praha, Czech Republic., Cmunt E; Department of Internal medicine, Hematology, General University Hospital, Praha, Czech Republic., Bělohlávková P; Department of Internal Medicine IV, Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic., Žák P; Department of Internal Medicine IV, Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic., Faber E; Department of Hematology-Oncology, University Hospital Olomouc, Olomouc, Czech Republic., Papajík T; Department of Hematology-Oncology, University Hospital Olomouc, Olomouc, Czech Republic., Stejskal L; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic., Ježíšková I; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Weinbergerová B; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Jurček T; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Horňák T; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Žáčková D; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Ransdorfová Š; Institute of Hematology and Blood Transfusion, Praha, Czech Republic., Holzerová M; Department of Hematology-Oncology, University Hospital Olomouc, Olomouc, Czech Republic., Pavlík T; Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic.; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Source: American journal of hematology [Am J Hematol] 2025 Apr; Vol. 100 (4), pp. 729-734. Date of Electronic Publication: 2025 Jan 28.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1096-8652
DOI:10.1002/ajh.27608